SourceOne Global Partners and Qualitas Health form a strategic partnership to deliver patented, clinically proven algae-based omega-3 solutions to the global marketplace
07. August 2024 09:45 ET
|
SourceOne Global Partners
SourceOne and Qualitas Health form a strategic partnership to bring patented and clinically confirmed algae-based omega-3 to the global marketplace.
SourceOne Global Partners celebrates 20-year anniversary, reflecting on pioneering a best-in-class high bioavailability technology platform
07. September 2023 11:39 ET
|
SourceOne Global Partners
CHICAGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- SourceOne Global Partners is proud to announce the launch of new, science-backed product solutions as it celebrates twenty years as a leading supplier to...
Geocann and Averix Bio form a strategic partnership to supply the global marketplace with pharmaceutical API phytocannabinoid ingredients formulated with a clinically proven drug delivery system technology
13. April 2022 09:04 ET
|
Geocann
FORT COLLINS, Colo., April 13, 2022 (GLOBE NEWSWIRE) -- Geocann is proud to announce a strategic partnership with Averix Bio that will bring U.S.-produced API phytocannabinoid ingredients and...
Theralogix is first to launch an NSF International certified CBD softgel powered by the clinically proven VESIsorb® technology
11. April 2022 23:19 ET
|
Geocann
FORT COLLINS, Colo., April 11, 2022 (GLOBE NEWSWIRE) -- Geocann and Theralogix are proud to announce the successful launch of a cannabidiol (CBD) and beta-caryophyllene (BCP) softgel formulation...
Nestlé Health Science expands distribution of hemp products formulated with VESIsorb® into Europe under industry-leading brand, Pure Encapsulations®
11. September 2020 08:45 ET
|
Geocann
FORT COLLINS, Colo., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Geocann and Nestlé Health Science are proud to announce the European launch of CBD (from broad spectrum hemp extract) soft gel formulations...
Geocann and Sunderstorm enter agreement to expand California leadership position across the U.S. with VESIsorb® formulated cannabis products
01. September 2020 11:34 ET
|
Geocann
FORT COLLINS, Colo., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce a strategic partnership with Sunderstorm that will bring VESIsorb® formulated cannabis products to millions of...
Geocann inks supply and distribution agreement with Opticann, a new U.S.-based company founded by former MedReleaf executives
06. August 2020 16:00 ET
|
Geocann
FORT COLLINS, Colo., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce a strategic partnership with Opticann Inc. (“Opticann”) that will bring VESIsorb® formulated hemp products into...
Geocann introduces the industry’s first 4-in-1 immunity support formulation utilizing the patented VESIsorb® drug delivery system
30. Juli 2020 19:00 ET
|
Geocann
FORT COLLINS, Colo., July 30, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has commercialized the first oral dose application that overcomes the well-known bioavailability...
Geocann’s VESIsorb® cannabidiol formulation delivers superior pharmacokinetic performance in published study
14. April 2020 12:00 ET
|
Geocann
FORT COLLINS, Colo., April 14, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the peer-reviewed journal, Molecules, has published the results of a double-blind, cross-over study...
Geocann is first-to-market introducing cannabigerol (CBG) formulations utilizing the VESIsorb® drug delivery system
23. August 2019 11:00 ET
|
Geocann
FORT COLLINS, Colo., Aug. 23, 2019 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has successfully commercialized the first cannabigerol (CBG) soft gel products that utilize the...